Neuropeptide Y levels in ethanol-naive, alcohol-preferring, and nonpreferring rats and in Wistar rats after ethanol exposure

被引:112
作者
Ehlers, CL
Li, TK
Lumeng, L
Hwang, BH
Somes, C
Jimenez, P
Mathé, AA
机构
[1] Scripps Res Inst, Dept Neuropharmacol, La Jolla, CA 92037 USA
[2] Indiana Univ, Sch Med, Indianapolis, IN USA
[3] Vet Affairs Med Ctr, Indianapolis, IN USA
[4] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden
关键词
alcohol-preferring rats; neuropeptide Y (NPY); amygdala; hypothalamus; alcoholism;
D O I
10.1111/j.1530-0277.1998.tb03979.x
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Neuropeptide Y (NPY) is a hexatriacontapeptide amide that is now well characterized as a neuromodulator in the central nervous system (CNS), When infused into the CNS, NPY produces both anxiolytic end orexigenic effects. NPY's anxiolytic effects appear to be mediated through receptors in the central amygdala, whereas its orexigenic effects are localized in discrete hypothalamic nuclei. Both food restriction and food deprivation produce increased revels of the peptide in the hypothalamus that are ameliorated by refeeding. However, the effects of alcohol consumption/deprivation on NPY levels remain unknown. The present study sought to determine if brain NPY levels were affected by either alcohol exposure and/or correlated with genetic differences in preference for drinking alcohol. In the first experiment, NPY-like immunoreactivity (NPY-LI) was compared in alcohol-naive, alcohol-preferring (P), and nonpreferring (NP) rats. After tissue extraction, NPY-LI was measured by radioimmunoassay: amygdala, hippocampus, frontal cortex, hypothalamus, and caudate. P rats were found to have significantly lower NPY-LI in amygdala (F = 4.69, p < 0.04), hippocampus (F = 7.03, p < 0.01), and frontal cortex (F = 4.7, p < 0.04), compared with NP rats. In the second experiment, heterozygous Wistar rats were exposed to alcohol for 14 hr/day for 7 weeks in alcohol vapor chambers (mean blood alcohol concentrations = 180 mg%) or control chambers. At 7 weeks of alcohol exposure, no significant changes in NPY-LI in were found. At 1 month after ethanol withdrawal, however, the ethanol-exposed animals had significantly higher NPY-LI in the hypothalamus (F = 4.78, p < 0.04) when compared with the nonexposed controls. Taken together, these studies suggest that exposure to chronic ethanol may affect NPY-LI at the level of the hypothalamus in a fashion similar to food restriction, because 4 weeks after alcohol withdrawal, significantly higher NPY levels are found. In addition, differences in NPY-LI in limbic areas and frontal cortex between alcohol-naive P and NP rats suggest that NPY may also play a role in risk for the development of alcohol preference either by modulating the "tension-reduction'' properties of alcohol or by influencing consummatory behaviors.
引用
收藏
页码:1778 / 1782
页数:5
相关论文
共 48 条
[1]   ALTERED EXPRESSION OF HYPOTHALAMIC NEUROPEPTIDE MESSENGER-RNAS IN FOOD-RESTRICTED AND FOOD-DEPRIVED RATS [J].
BRADY, LS ;
SMITH, MA ;
GOLD, PW ;
HERKENHAM, M .
NEUROENDOCRINOLOGY, 1990, 52 (05) :441-447
[2]   Anxiolytic activity of NPY receptor agonists in the conflict test [J].
Britton, KT ;
Southerland, S ;
VanUden, E ;
Kirby, D ;
Rivier, J ;
Koob, G .
PSYCHOPHARMACOLOGY, 1997, 132 (01) :6-13
[3]   EINE SPEZIFISCHE PHOTOMETRISCHE BESTIMMUNG VON ATHYLALKOHOL AUF FERMENTATIVEM WEGE [J].
BUCHER, T ;
REDETZKI, H .
KLINISCHE WOCHENSCHRIFT, 1951, 29 (35-3) :615-616
[4]   INCREASE OF NEUROPEPTIDE Y-LIKE IMMUNOREACTIVITY IN THE PARAVENTRICULAR NUCLEUS OF FASTING RATS [J].
CALZA, L ;
GIARDINO, L ;
BATTISTINI, N ;
ZANNI, M ;
GALETTI, S ;
PROTOPAPA, F ;
VELARDO, A .
NEUROSCIENCE LETTERS, 1989, 104 (1-2) :99-104
[5]  
CAPELL H, 1972, Q J STUD ALCOHOL, V33, P33
[6]   NEUROPEPTIDE-Y AND HUMAN PANCREATIC-POLYPEPTIDE STIMULATE FEEDING-BEHAVIOR IN RATS [J].
CLARK, JT ;
KALRA, PS ;
CROWLEY, WR ;
KALRA, SP .
ENDOCRINOLOGY, 1984, 115 (01) :427-429
[7]  
DEITRICH RA, 1984, RES ADV ALCOHOL DRUG, V8, P47
[8]   CORTICOTROPIN RELEASING-FACTOR (CRF) - STUDIES IN ALCOHOL PREFERRING AND NONPREFERRING RATS [J].
EHLERS, CL ;
CHAPLIN, RI ;
WALL, TL ;
LUMENG, L ;
LI, TK ;
OWENS, MJ ;
NEMEROFF, CB .
PSYCHOPHARMACOLOGY, 1992, 106 (03) :359-364
[9]  
Ehlers CL, 1997, NEUROPSYCHOPHARMACOL, V17, P34
[10]  
EHLERS CL, IN PRESS PSYCHOPHARM